Dr Agarwal Healthcare’s IPO debut: A slow start at ₹402

Shares of Dr Agarwal Healthcare entered the equity markets on Tuesday, February 4, 2025, with a lacklustre entry. On the NSE, the stock opened at ₹402 per share, aligning with its IPO price. Meanwhile, on the Bombay Stock Exchange (BSE), it opened at ₹396.90 per share, marking a 1.27% decline from its issue price.

The IPO, which was available for subscription from January 29, 2025, to January 31, 2025, received a mixed response from investors across categories. The final allotment was completed on February 3, 2025.

Dr Agarwal's IPO details

The IPO was completely subscribed on the closing day, achieving an overall subscription of 1.55 times. The total bids received were 8,32,18,380 shares, compared to the 5,35,26,172 shares on offer.

1. Qualified Institutional Buyers (QIBs) were the major contributors, subscribing 4.64 times their allocated quota.
2. Non-institutional investors (NIIs) subscribed to just 40% of their reserved portion.
3. Retail individual investors (RIIs) applied for 41% of their quota.
4. Employees subscribed to just 27% of their reserved portion.

The IPO comprised a fresh issue worth ₹300 crore and an offer-for-sale (OFS) valued at ₹2,727.26 crore. The price band was set at ₹382-₹402 per share, and investors could apply for a minimum of one lot consisting of 35 shares, requiring an investment of at least ₹14,070.

Should investors worry about the muted listing?

A sluggish listing often raises concerns, but market performance post-listing depends on multiple factors, including industry trends, financial performance, and broader market sentiment. Dr Agarwal Healthcare provides a range of services, including refractive and cataract surgeries, diagnosis, and optical product sales. These offerings position the company in a growing healthcare segment, which could attract investors looking to invest in stocks with long-term potential.

Is this a good time to invest in stocks?

While Dr Agarwal Healthcare's listing was not as dynamic as some had expected, market experts suggest that long-term investors should assess fundamentals rather than focusing solely on listing-day performance.

Those looking to invest in stocks should consider a company's growth trajectory, sector performance, and financials before making a decision. As the healthcare sector continues to evolve, investors will be keen to see how Dr Agarwal Healthcare performs in the coming months. However, on February 4, 2025, at 11:51 AM, Dr Aggarwal's IPO saw a decline of over 7%.